As shown in Figure 5B, although both gene expression-based (green bars) and TFA-based (gold bars) breast PTEN IHC-based signatures can be used to predict PTEN status by unsupervised clustering approach in human breast cancers, they failed to do so for prostate cancers and brain tumors. Here, PTEN is linked to prostate carcinoma.